Join to View Full Profile
1720 2nd Avenue SouthNP2540F North PavilionBirmingham, AL 35294
Phone+1 205-934-2248
Fax+1 949-698-6272
Dr. Narkhede is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- MedStar Health Georgetown UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019
- Cleveland Clinic FoundationResidency, Internal Medicine, 2014 - 2016
- Cleveland Clinic FoundationInternship, Internal Medicine, 2013 - 2014
- KJ Somaiya Medical CollegeClass of 2006
Certifications & Licensure
- AL State Medical License 2019 - 2025
- DC State Medical License 2016 - 2020
- OH State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy Start of enrollment: 2021 Nov 15
Roles: Principal Investigator, Contact
- Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia Start of enrollment: 2023 Dec 18
Roles: Sponsor-Investigator, Principal Investigator, Contact
- PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL Start of enrollment: 2024 Aug 30
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma in the United States.Lauren Shea, Mayur Narkhede, Karthik Chamarti, Tina Gao, Amitkumar Mehta
Ejhaem. 2025-04-01 - Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study.Mohamed A Kharfan-Dabaja, Razan Mohty, Neela Easwar, Patrick Johnston, Madiha Iqbal
Bone Marrow Transplantation. 2025-03-01 - 1 citationsLoncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers.Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha
Haematologica. 2025-03-01
Lectures
- External Validation and Revision of Thrombosis Lymphoma /Throly/ Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Lack of Prognostic Significance of Pre-Treatment Total Metabolic Tumor Volume (TMTV) in Diffuse Large B-Cell Lymphoma (DLBCL)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
